Robert Hershberg

Insider Reports History

Entity
Individual
Location
3005 First Avenue, Seattle, WA
Signature
/s/Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Hershberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HilleVax, Inc. President and Chief Executive Officer, Director Common Stock 1.13M $16.8M $14.93 Feb 8, 2024 Direct
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 51.7K $454K $8.78 Jun 3, 2024 Direct
Adaptive Biotechnologies Corp Director Common Stock 107K $368K $3.43 Mar 4, 2024 Direct
FATE THERAPEUTICS INC Director Stock Option (Right to Buy) 40K $109K $2.73 Jun 6, 2023 Direct
NanoString Technologies Inc Director Common Stock 10.7K $23.5K $2.19 Apr 18, 2022 Direct
HilleVax, Inc. President and Chief Executive Officer, Director Stock Option (Right to Buy) 227K Feb 8, 2024 Direct
Adaptive Biotechnologies Corp Director Stock Option (right to buy) 48K Mar 4, 2024 Direct
RECURSION PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 26.2K Jun 3, 2024 Direct
Silverback Therapeutics, Inc. Director Stock Option (right to buy) 18K Jun 10, 2022 Direct

Insider Reports Filed by Robert Hershberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. Jun 3, 2024 2 $0 4 Jun 5, 2024 Director
ADPT Adaptive Biotechnologies Corp Mar 4, 2024 2 $0 4 Mar 6, 2024 Director
HLVX HilleVax, Inc. Feb 8, 2024 3 -$173K 4 Feb 12, 2024 President and Chief Executive Officer, Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
FATE FATE THERAPEUTICS INC Jun 6, 2023 1 $0 4 Jun 7, 2023 Director
ADPT Adaptive Biotechnologies Corp Mar 6, 2023 2 $0 4 Mar 8, 2023 Director
ADPT Adaptive Biotechnologies Corp Feb 2, 2023 2 $23.9K 4 Feb 3, 2023 Director
HLVX HilleVax, Inc. Feb 1, 2023 2 $0 4 Feb 3, 2023 President and CEO, Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
SPRY Silverback Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
FATE FATE THERAPEUTICS INC Jun 9, 2022 2 $0 4 Jun 13, 2022 Director
FATE FATE THERAPEUTICS INC Jun 3, 2022 1 -$15.3K 4 Jun 6, 2022 Director
HLVX HilleVax, Inc. Apr 28, 2022 0 $0 3 Apr 28, 2022 President and CEO, Director
NSTG NanoString Technologies Inc Apr 18, 2022 2 $0 4 Apr 18, 2022 Director
ADPT Adaptive Biotechnologies Corp Jan 26, 2022 2 $0 4 Jan 28, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Oct 1, 2021 1 $0 4 Oct 5, 2021 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 1, 2021 1 $0 4 Jul 6, 2021 Director
NSTG NanoString Technologies Inc Jun 15, 2021 3 $0 4 Jun 17, 2021 Director
SPRY Silverback Therapeutics, Inc. Jun 4, 2021 1 $0 4 Sep 21, 2021 Director
FATE FATE THERAPEUTICS INC Jun 2, 2021 2 $0 4 Jun 4, 2021 Director